Results 81 to 90 of about 26,095 (148)

Supporting treatment decision-making for patients with multiple myeloma post-DRd in Italy: a multi-criteria decision framework. [PDF]

BMC Cancer
Boccadoro M, Belotti A, Bombaci F, Bringhen S, Buda G, Cafro AM, Caimmi M, Canali B, Canonico PL, Cavo M, Corso A, De Paoli L, Derudas D, Di Raimondo F, Galeone C, Gay F, Gentile M, Giuliani N, La Malfa P, Mercati R, Montefusco V, Musto P, Offidani M, Patriarca F, Petrucci MT, Riccaboni M, Tosi P, Zamagni E, Zambello R, Fiorentino F.   +29 more
europepmc   +1 more source

Haemodynamic Forces: Emerging Markers of Ventricular Remodelling in Multiple Myeloma Cardiovascular Baseline Risk Assessment. [PDF]

Cancers (Basel)
Colomba A, Astarita A, Mingrone G, Airale L, Catarinella C, Vallelonga F, Leone D, Cesareo M, Paladino A, Bringhen S, Gay F, Pedrizzetti G, Veglio F, Milan A.   +13 more
europepmc   +1 more source

C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: a diagnostic and therapeutic challenge. [PDF]

J Bras Nefrol
Beirão B, Freitas M, Silva N, Ferraz P, Prata C, Morgado T.   +5 more
europepmc   +2 more sources

Liposomal daunorubicin and dexamethasone as a treatment for multiple myeloma--the DD Protocol. [PDF]

Sao Paulo Med J, 2005
Dulley FL, Saboya R, Hungria VT, Bueno ND, Mello FG, Frota MT, Chiattone CS, Barros JC, Mori NS, Sturaro D, Macedo MC, Silva RL, Melo LM, Souza CA.   +13 more
europepmc   +1 more source

Correlation of the Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratios with Postoperative Complications and Survival in Surgery for Bone Metastasis of the Appendicular Skeleton. [PDF]

Rev Bras Ortop (Sao Paulo)
Teixeira MS, Teixeira AVR, Mello GJP, Tabushi FI, Franck CL, Ribas CAPM.   +5 more
europepmc   +1 more source

Day zero of autologous cryopreserved hematopoietic stem cell transplantation: microcosting of care provided by senior nurses. [PDF]

Rev Esc Enferm USP
Nunes VAG, Lima AFC.
europepmc   +1 more source

Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019. [PDF]

ESMO Real World Data Digit Oncol
Moscetti L, Barbieri E, Zattarin E, Vici P, Zoppoli G, Musolino A, Natalizio S, Canino F, Ravera F, Filomeno L, Arcuri T, Omarini C, Piacentini F, Barbolini M, Cortesi L, Caggia F, Civallero M, Dominici M, Toss A.   +18 more
europepmc   +1 more source